Participant Characteristics and HIV Risk Behaviors Among Individuals Entering Integrated Buprenorphine/Naloxone and HIV Care

Chaudhry, Amina A; Botsko, Michael; Weiss, Linda; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 56():S14-S21, March 1, 2011.

Drug Treatment Outcomes Among HIV-Infected Opioid-Dependent Patients Receiving Buprenorphine/Naloxone

Fiellin, David A; Weiss, Linda; Botsko, Michael; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 56():S33-S38, March 1, 2011.

Improved Quality of Life for Opioid-Dependent Patients Receiving Buprenorphine Treatment in HIV Clinics

Korthuis, P Todd; Tozzi, Mary Jo; Nandi, Vijay; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 56():S39-S45, March 1, 2011.

Integration of Buprenorphine/Naloxone Treatment into HIV Clinical Care: Lessons From the BHIVES Collaborative

Weiss, Linda; Netherland, Julie; Egan, James E; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 56():S68-S75, March 1, 2011.

The Cost of Integrated HIV Care and Buprenorphine/Naloxone Treatment: Results of a Cross-Site Evaluation

Schackman, Bruce R; Leff, Jared A; Botsko, Michael; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 56():S76-S82, March 1, 2011.